Bristol-Myers Squibb (Japan)

276 papers and 5.9k indexed citations i.

About

In recent decades, authors affiliated with Bristol-Myers Squibb (Japan) have published 276 papers, which have received a total of 5.9k indexed citations. Scholars at this organization have produced 68 papers in Oncology, 64 papers in Molecular Biology and 36 papers in Pharmacology on the topics of Hepatitis C virus research (28 papers), Microbial Natural Products and Biosynthesis (23 papers) and Chronic Lymphocytic Leukemia Research (21 papers). Their work is cited by papers focused on Molecular Biology (1.7k citations), Epidemiology (1.2k citations) and Pharmacology (1.1k citations). Authors at Bristol-Myers Squibb (Japan) collaborate with scholars in Japan, United States and Germany and have published in prestigious journals including Journal of Clinical Oncology, Blood and PLoS ONE. Some of Bristol-Myers Squibb (Japan)'s most productive authors include MASATAKA KONISHI, TOSHIKAZU OKI, Hideo Kamei, Hiroshi Kawaguchi and Takeo Miyaki.

In The Last Decade

Fields of papers published by authors at Bristol-Myers Squibb (Japan)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Bristol-Myers Squibb (Japan) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Bristol-Myers Squibb (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Bristol-Myers Squibb (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Bristol-Myers Squibb (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bristol-Myers Squibb (Japan) more than expected).

Rankless by CCL
2025